WHO-Chelating agents

Description

WHO is developing guidelines on the management of lead poisoning. A key part of the management of moderate to severe lead poisoning is the use of chelation therapy. DUK will assist WHO grading the quality of evidence (using GRADE). In addition, a systematic evidence review is planned on the use of nutritional enhancements in lead poisoning for which the input of a GRADE expert will be required.

Details

Duration 15/06/2015 - 30/09/2015
Funding Sonstige
Program ---
Department

Department for Evidence-based Medicine and Evaluation

Principle investigator for the project (Danube University Krems) Dr. Peter Mahlknecht

Team

Dr. Peter Mahlknecht

Back to top

 

To Glossary

This website uses cookies to improve your user experience, for analytical purposes for optimizing our systems and for marketing purposes. By clicking on „OK" or continuing to browse the site, you are agreeing to the use of cookies. More information concerning privacy policy and data protection official.

OK